Skip to main content
AZTA
NASDAQ Life Sciences

Azenta Q4 Adjusted EPS of 28 Cents Nearly Triples the 11-Cent Consensus

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$44.2
Mkt Cap
$1.773B
52W Low
$15.93
52W High
$46.41
52W Position info
177% above low
Off High info
4.8% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

AZTA has more than doubled off its 52-week low of $15.93.

Summary

Azenta closed fiscal 2026 with adjusted EPS of 28 cents a share, well above the 11-cent consensus and up from 21 cents a year earlier. Revenue rose 5% to $167.09 million, topping the $160.13 million analysts expected, and GAAP net income came in at $6.79 million, or 16 cents a share. The beat lands after a rough stretch of estimate cuts — the mean earnings estimate fell about 34% over the past three months and three analysts revised lower in the last 30 days — so the bar was low. It also follows the October 7 restructuring of the Multiomics segment, which closed three North American labs and cut jobs, and the August CEO transition to interim chief Dr. Martin Madaus. The stock is trading near its 52-week high of $46.41, and the median analyst price target of $38.50 sits below the last close of $40.95, so the beat has to carry the multiple from here.

At the time of this announcement, AZTA was trading at $44.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $15.93 to $46.41. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AZTA - Latest Insights

AZTA
Nov 10, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $39.99
Real-time Price: $44.20 info
Change: +$4.21 (+11%) info
Market Cap: $1.773B info
AZTA
Oct 30, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $39.87
Real-time Price: $44.20 info
Change: +$4.33 (+11%) info
Market Cap: $1.773B info
AZTA
Oct 07, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $40.04
Real-time Price: $44.20 info
Change: +$4.16 (+10%) info
Market Cap: $1.773B info
AZTA
Aug 24, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.90
Real-time Price: $44.20 info
Change: +$7.30 (+20%) info
Market Cap: $1.773B info
AZTA
Aug 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.74
Real-time Price: $44.20 info
Change: +$13.46 (+44%) info
Market Cap: $1.773B info